Management

Dr. Rantuccio joined Curis in April 2024 as Vice President, Regulatory Affairs. Prior to joining Curis, Dr. Rantuccio served as Vice President of Regulatory Affairs and Medical Writing at HUTCHMED,  where she was responsible for developing global regulatory strategies across the company’s oncology focused pipeline, as well as managing the regulatory affairs and medical writing teams. Dr. Rantuccio previously held positions of increasing responsibilities at Johnson & Johnson (Janssen), Novartis, and Hofmann-La Roche.   She received her Pharm.D. from the University of Nebraska Medical Center.